We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
Sekisui Diagnostics UK Ltd.

Download Mobile App


13 Jun 2024 - 15 Jun 2024
18 Jun 2024 - 20 Jun 2024

Minimally Invasive Procedure Offers Alternative to Open-Heart Surgery for Aortic Stenosis

By HospiMedica International staff writers
Posted on 26 Oct 2023
Print article
Image: A new study supports a minimally invasive procedure for aortic stenosis (Photo courtesy of 123RF)
Image: A new study supports a minimally invasive procedure for aortic stenosis (Photo courtesy of 123RF)

The aortic valve is one of the heart's four valves that manage blood flow by opening and closing at the right times. When the aortic artery narrows, a condition known as aortic stenosis develops, limiting the valve's ability to fully open and thus disrupting the flow of blood within the heart and to the body. Back in 2011, the U.S. Food and Drug Administration gave the green light to a procedure called transcatheter aortic valve replacement (TAVR) for individuals with severe aortic stenosis who are prone to complications from surgery. These days, TAVR and other minimally invasive approaches are increasingly being presented as an alternative to traditional surgery. A recent study now shows that outcomes for patients who had a dysfunctional aortic valve and received a prosthetic one through TAVR were comparable to those who had open-heart surgery five years down the line.

The international multicenter study, which included researchers from Cedars-Sinai (Los Angeles, CA, USA), involved patients from healthcare facilities in the United States, Australia, Canada, Japan, and New Zealand. About 1,000 individuals diagnosed with severe, symptomatic aortic stenosis were randomly selected to undergo either TAVR or open-heart surgery. Of these, 496 were treated with TAVR and 454 had surgery. Notably, all these patients were evaluated as having a low risk of complications from surgery.

The research team closely monitored the patients, conducting assessments before the treatment, immediately after, upon leaving the hospital, 30 days later, six months afterward, and then annually for five years. When it came to the rates of death, stroke, and the need for rehospitalization five years after the treatments, the outcomes for both the TAVR and surgery groups were quite similar. Specifically, 111 out of 496 TAVR patients and 117 out of 454 surgical patients had incidents related to death, stroke, or rehospitalization due to issues with the newly placed valve, the procedure itself, or heart failure. These results are in line with previous trials that had examined the outcomes for TAVR and surgery patients at one, two, and three years after their respective treatments.

“Our data at five years validate that TAVR is a good alternative to open-heart surgery in younger patients with aortic stenosis,” said Raj Makkar, MD, Cedars-Sinai’s vice president of Cardiovascular Innovation and Intervention, associate director of the Smidt Heart Institute and the study’s senior author. “They support routinely offering TAVR, even to patients for whom open-heart surgery wouldn’t pose a high risk.”

Related Links:

Gold Member
12-Channel ECG
Gold Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Silver Member
Wireless Mobile ECG Recorder
Guide Wire

Print article


Surgical Techniques

view channel
Image: The researchers tweaked borophene to interact with cells and other biological units in unique ways (Photo courtesy of Dipanjan Pan/Penn State)

New Two-Dimensional Material Paves Way for Safer, More Effective Implantable Medical Devices

Borophene, first synthesized in 2015, is an atomically thin version of boron that surpasses graphene—the two-dimensional (2D) version of carbon—in conductivity, thinness, lightness, strength, and flexibility.... Read more

Patient Care

view channel
Image: The portable, handheld BeamClean technology inactivates pathogens on commonly touched surfaces in seconds (Photo courtesy of Freestyle Partners)

First-Of-Its-Kind Portable Germicidal Light Technology Disinfects High-Touch Clinical Surfaces in Seconds

Reducing healthcare-acquired infections (HAIs) remains a pressing issue within global healthcare systems. In the United States alone, 1.7 million patients contract HAIs annually, leading to approximately... Read more

Health IT

view channel
Image: First ever institution-specific model provides significant performance advantage over current population-derived models (Photo courtesy of Mount Sinai)

Machine Learning Model Improves Mortality Risk Prediction for Cardiac Surgery Patients

Machine learning algorithms have been deployed to create predictive models in various medical fields, with some demonstrating improved outcomes compared to their standard-of-care counterparts.... Read more

Point of Care

view channel
Image: The Quantra Hemostasis System has received US FDA special 510(k) clearance for use with its Quantra QStat Cartridge (Photo courtesy of HemoSonics)

Critical Bleeding Management System to Help Hospitals Further Standardize Viscoelastic Testing

Surgical procedures are often accompanied by significant blood loss and the subsequent high likelihood of the need for allogeneic blood transfusions. These transfusions, while critical, are linked to various... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.